Rheumatoid Arthritis Completed Phase 1 / 2 Trials for Rituximab (DB00073)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01274182GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard TherapyTreatment
NCT01526057A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)Treatment
NCT01123070TL011 in Severe, Active Rheumatoid Arthritis PatientsTreatment